Medecision, Inc. - Current report filing (8-K)
22 4월 2008 - 4:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported):
|
April 21, 2008
|
MEDecision, Inc.
(Exact Name of Issuer as Specified in Charter)
Pennsylvania
(State or Other Jurisdiction of Incorporation or
Organization)
|
|
001-33191
(Commission File Number)
|
|
23-2530889
(I.R.S. Employer Identification
Number)
|
|
|
|
|
|
601 Lee Road, Chesterbrook
Corporate Center
Wayne, Pennsylvania
(Address of Principal Executive Offices)
|
|
19087
(Zip Code)
|
(610) 540-0202
(Registrants Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
o
|
|
Written
communications pursuant to Rule 425 under the Securities Act
|
o
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
|
o
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
|
o
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
|
Item 5.02.
Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Appointment
of Timothy W. Wallace as Interim President and Chief Operating Officer
On April 21, 2008,
MEDecision, Inc. (the Company) announced that Timothy W. Wallace had
been appointed to serve as the Companys Interim President and Chief Operating
Officer. Mr. Wallace, age 50, joined
the Company in March 2002 as a member of the Board of Directors. From April 2000 until March 2008,
he served as the Chief Executive Officer of FullTilt Solutions, Inc., an
enterprise product information management software company, and since April 2000
has served as its Chairman. Mr. Wallace
is a Certified Public Accountant (inactive). Mr. Wallace received a B.S.
in Accounting from Indiana University of Pennsylvania and a M.B.A. from Miami
University.
Under the terms of his
Consulting Agreement (Consulting Agreement), Mr. Wallace will receive a
payment of $6,500 for each week that he serves as Interim President and Chief
Operating Officer. The Company also agreed
to continue to pay Mr. Wallace for his service as a member of the Board of
Directors, except for service on any committees of the Board of Directors. Due to the nature of the consulting responsibilities
contemplated, the Consulting Agreement prohibits Mr. Wallace from
accepting engagements that will interfere with the performance of his duties as
Interim President and Chief Operating Officer of the Company. The Consulting Agreement is terminable, upon
thirty days notice, by either party. Mr. Wallace
has also agreed to certain restrictive covenants, including confidentiality and
non-competition and non-solicitation provisions during his engagement with the
Company and for a period of twelve months thereafter.
The foregoing description of
the Consulting Agreement is qualified in its entirety by reference to the full
text of the Consulting Agreement, a copy of which is attached as Exhibit 10.1
to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) The following
exhibits are furnished with this Form 8-K:
Exhibit No.
|
|
Description
|
|
|
|
10.1
|
|
Consulting Agreement dated
April 21, 2008 between MEDecision, Inc. and Timothy W. Wallace
|
|
|
|
99.1
|
|
Press Release of
MEDecision, Inc. dated April 21, 2008
|
2
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
|
|
MEDECISION, INC.
|
|
|
|
|
|
|
Date:
April 21, 2008
|
|
By:
|
/s/
Carl E. Smith
|
|
|
|
Name:
|
Carl
E. Smith
|
|
|
Title:
|
Executive
Vice President and
|
|
|
|
Chief
Financial Officer
|
3
EXHIBIT INDEX
Exhibit
Number
|
|
Description
|
10.1
|
|
Consulting
Agreement dated April 21, 2008 between MEDecision, Inc. and Timothy
W. Wallace
|
99.1
|
|
Press
Release of MEDecision, Inc. dated April 21, 2008
|
4
Medecision (MM) (NASDAQ:MEDE)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Medecision (MM) (NASDAQ:MEDE)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025